These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 34319381)

  • 1. Colorectal Strictures in Patients With Inflammatory Bowel Disease Do Not Independently Predict Colorectal Neoplasia.
    Axelrad JE; Faye A; Slaughter JC; Harpaz N; Itzkowitz SH; Shah SC
    Inflamm Bowel Dis; 2022 Jun; 28(6):855-861. PubMed ID: 34319381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease.
    Shah SC; Ten Hove JR; Castaneda D; Palmela C; Mooiweer E; Colombel JF; Harpaz N; Ullman TA; van Bodegraven AA; Jansen JM; Mahmmod N; van der Meulen-de Jong AE; Ponsioen CY; van der Woude CJ; Oldenburg B; Itzkowitz SH; Torres J
    Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1106-1113.e3. PubMed ID: 29378311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin Exposure Is Not Associated with Reduced Prevalence of Colorectal Neoplasia in Patients with Inflammatory Bowel Disease.
    Shah SC; Glass J; Giustino G; Hove JRT; Castaneda D; Torres J; Kumar A; Elman J; Ullman TA; Itzkowitz SH
    Gut Liver; 2019 Jan; 13(1):54-61. PubMed ID: 30400722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Indefinite Dysplasia and Advanced Neoplasia in Patients With Inflammatory Bowel Diseases Undergoing Surveillance.
    Mahmoud R; Shah SC; Torres J; Castaneda D; Glass J; Elman J; Kumar A; Axelrad J; Harpaz N; Ullman T; Colombel JF; Oldenburg B; Itzkowitz SH
    Clin Gastroenterol Hepatol; 2020 Jun; 18(7):1518-1527.e3. PubMed ID: 31446183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No Association Between Pseudopolyps and Colorectal Neoplasia in Patients With Inflammatory Bowel Diseases.
    Mahmoud R; Shah SC; Ten Hove JR; Torres J; Mooiweer E; Castaneda D; Glass J; Elman J; Kumar A; Axelrad J; Ullman T; Colombel JF; Oldenburg B; Itzkowitz SH;
    Gastroenterology; 2019 Apr; 156(5):1333-1344.e3. PubMed ID: 30529584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk and incidence of colorectal stricture progressing to colorectal neoplasia in patients with inflammatory bowel disease: a systematic review and meta-analysis.
    Zhan Y; Cheng X; Mei P; Wu J; Ou Y; Cui Y
    Eur J Gastroenterol Hepatol; 2023 Oct; 35(10):1075-1087. PubMed ID: 37577790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nearly a Third of High-Grade Dysplasia and Colorectal Cancer Is Undetected in Patients with Inflammatory Bowel Disease.
    Eluri S; Parian AM; Limketkai BN; Ha CY; Brant SR; Dudley-Brown S; Efron JE; Fang SG; Gearhart SL; Marohn MR; Meltzer SJ; Bashar S; Truta B; Montgomery EA; Lazarev MG
    Dig Dis Sci; 2017 Dec; 62(12):3586-3593. PubMed ID: 28631086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smoking and colorectal neoplasia in patients with inflammatory bowel disease: Dose-effect relationship.
    Wijnands AM; Elias SG; Dekker E; Fidder HH; Hoentjen F; Ten Hove JR; Maljaars PWJ; van der Meulen-de Jong AE; Mooiweer E; Ouwehand RJ; Penning de Vries BBL; Ponsioen CY; van Schaik FDM; Oldenburg B;
    United European Gastroenterol J; 2023 Sep; 11(7):612-620. PubMed ID: 37505117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of low-grade dysplasia to advanced neoplasia based on the location and morphology of dysplasia in ulcerative colitis patients with extensive colitis under colonoscopic surveillance.
    Navaneethan U; Jegadeesan R; Gutierrez NG; Venkatesh PG; Hammel JP; Shen B; Kiran RP
    J Crohns Colitis; 2013 Dec; 7(12):e684-91. PubMed ID: 23916526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-Grade Dysplasia in Inflammatory Bowel Disease: Indication for Colectomy.
    Olecki EJ; Perez Hoguin RA; King S; Razavi NC; Scow JS
    Dis Colon Rectum; 2023 Feb; 66(2):262-268. PubMed ID: 35714339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Colorectal Neoplasia Risk in Patients with Inflammatory Bowel Disease and Serrated Polyps with Dysplasia.
    de Jong ME; Nagtegaal ID; Vos S; van der Post RS; van Herwaarden Y; Derikx LAAP; Hoentjen F
    Dig Dis Sci; 2022 Dec; 67(12):5647-5656. PubMed ID: 35380348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory bowel disease as a risk factor for colorectal cancer.
    Lukas M
    Dig Dis; 2010; 28(4-5):619-624. PubMed ID: 21088413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
    Venkatesh PG; Jegadeesan R; Gutierrez NG; Sanaka MR; Navaneethan U
    J Crohns Colitis; 2013 Dec; 7(12):968-73. PubMed ID: 23433613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance for Colorectal Neoplasia in Inflammatory Bowel Disease: When to Stop.
    Axelrad JE; Cross RK
    Am J Gastroenterol; 2023 Mar; 118(3):429-431. PubMed ID: 36584365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Risk of Non-conventional and Invisible Dysplasias in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease.
    Zhang R; Lauwers GY; Choi WT
    J Crohns Colitis; 2022 Dec; 16(12):1825-1834. PubMed ID: 35771958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Random biopsies during surveillance colonoscopy increase dysplasia detection in patients with primary sclerosing cholangitis and ulcerative colitis.
    Navaneethan U; Kochhar G; Venkatesh PG; Bennett AE; Rizk M; Shen B; Kiran RP
    J Crohns Colitis; 2013 Dec; 7(12):974-81. PubMed ID: 23523416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?
    Dyson JK; Rutter MD
    World J Gastroenterol; 2012 Aug; 18(29):3839-48. PubMed ID: 22876036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of Surveillance Impacts the Colitis-Associated Advanced Neoplasia Risk: A Multicenter Case-Control Study.
    Te Groen M; Derks M; den Broeder N; Peters C; Dijkstra G; de Vries A; Romkens T; Horjus C; de Boer N; de Jong M; Nagtegaal I; Derikx L; Hoentjen F
    Clin Gastroenterol Hepatol; 2024 Feb; 22(2):357-367.e5. PubMed ID: 36572110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Appendectomy and Risk of Advanced Colorectal Neoplasia in Inflammatory Bowel Disease: A Nationwide Population-based Cohort Study.
    Mark-Christensen A; Kristiansen EB; Myrelid P; Laurberg S; Erichsen R
    Inflamm Bowel Dis; 2024 Jun; 30(6):877-883. PubMed ID: 37523678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
    Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.